Abstract | OBJECTIVE: To determine the relative importance of the cardiac and vascular sympathetic components of the orthostatic response to 90 degrees head-up tilt after N-type calcium-channel blockade in normotensive ( sham renal cellophane wrap) and hypertensive (renal wrap) conscious rabbits. METHODS: RESULTS: In vehicle ( 0.9% saline) treatment groups, the response to tilt consisted of a small pressor effect (4 +/- 2 and 7 +/- 1 mmHg) and tachycardia (29 +/- 6 and 17 +/- 6 beats/min) in sham (n = 6) and wrap (n = 5) rabbits, respectively. After prazosin administration (with cardiac block), there were significant falls in MAP of 3 +/- 1 and 7 +/- 2 mmHg in sham (n = 7) and wrap (n = 6) rabbits, respectively, in response to tilt omega-CTX caused postural hypotensive responses of 8 +/- 2 and 13 +/- 2 mmHg in sham (n = 6) and wrap (n = 7) rabbits, respectively, and 7 +/- 1 and 14 +/- 2 mmHg in sham (n = 7) and wrap (n = 7) rabbits with prior cardiac block. Similarly, mecamylamine caused falls in MAP of 8 +/- 1 and 10 +/- 2 mmHg in response to tilt in sham (n = 6) and wrap (n = 9) animals, respectively. CONCLUSION:
|
Authors | C E Wright, A L Hawkes, J A Angus |
Journal | Journal of hypertension
(J Hypertens)
Vol. 18
Issue 1
Pg. 65-73
(Jan 2000)
ISSN: 0263-6352 [Print] England |
PMID | 10678545
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic alpha-Agonists
- Adrenergic beta-Agonists
- Calcium Channel Blockers
- Calcium Channels, N-Type
- omega-Conotoxin GVIA
- Methoxamine
- Isoproterenol
|
Topics |
- Adrenergic alpha-Agonists
(pharmacology)
- Adrenergic beta-Agonists
(pharmacology)
- Animals
- Blood Pressure
(drug effects)
- Calcium Channel Blockers
(pharmacology)
- Calcium Channels, N-Type
(drug effects, metabolism)
- Female
- Heart Rate
(drug effects)
- Hypertension
(physiopathology)
- Hypotension, Orthostatic
(etiology, physiopathology)
- Isoproterenol
(pharmacology)
- Methoxamine
(pharmacology)
- Nasopharynx
(physiopathology)
- Rabbits
- Reflex
(drug effects)
- omega-Conotoxin GVIA
(pharmacology)
|